Damien Chopy is a Senior Director, Business Development Project Leader in the Roche Pharma Corporate Business Development team for 7 years. His curiosity and interest in cross-pollination between teams and therapeutic areas have contributed to the identification, informed decisions and transactions on complex and strategic opportunities to complement Roche and Genentech portfolio with innovative assets and emerging therapeutic modalities. Recently in Oncology, he had the pleasure to lead the setup of Roche partnership with Medilink on Ph1 cMet ADC and the acquisition of Poseida Therapeutics. Since joining Roche in 2013, Damien has held various roles with increased responsibilities at the interface of the sciences in the Roche Institute team (Roche France) prior to moving to the R&D unit in Basel. He is also part of the Steering Committee of Biofit.